| 21 |
GPL5278 |
AFFY Human Phase3 v1.0 - C45 |
3,631,683 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C45, |
| 22 |
GPL5252 |
AFFY Human Phase3 v1.0 - C19 |
3,572,706 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C19, |
| 23 |
GPL5251 |
AFFY Human Phase3 v1.0 - C18 |
3,546,698 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C18, |
| 24 |
GPL5264 |
AFFY Human Phase3 v1.0 - C31 |
3,538,846 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C31, |
| 25 |
GPL5254 |
AFFY Human Phase3 v1.0 - C21 |
3,529,698 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C21, |
| 26 |
GPL5286 |
AFFY Human Phase3 v1.0 - C53 |
3,506,325 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C53, |
| 27 |
GPL5304 |
AFFY Human Phase3 v1.0 - C71 |
3,469,894 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C71, |
| 28 |
GPL5238 |
AFFY Human Phase3 v1.0 - C05 |
3,469,626 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C05, |
| 29 |
GPL5263 |
AFFY Human Phase3 v1.0 - C30 |
3,419,810 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C30, |
| 30 |
GPL5268 |
AFFY Human Phase3 v1.0 - C35 |
3,391,105 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C35, |
| 31 |
GPL5314 |
AFFY Human Phase3 v1.0 - C81 |
3,390,098 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C81, |
| 32 |
GPL5320 |
AFFY Human Phase3 v1.0 - C87 |
3,329,019 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C87, |
| 33 |
GPL5318 |
AFFY Human Phase3 v1.0 - C85 |
3,318,218 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C85, |
| 34 |
GPL5309 |
AFFY Human Phase3 v1.0 - C76 |
3,253,740 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C76, |
| 35 |
GPL5323 |
AFFY Human Phase3 v1.0 - C90 |
3,241,033 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C90, |
| 36 |
GPL5294 |
AFFY Human Phase3 v1.0 - C61 |
3,233,611 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C61, |
| 37 |
GPL5236 |
AFFY Human Phase3 v1.0 - C03 |
3,223,204 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C03, |
| 38 |
GPL5242 |
AFFY Human Phase3 v1.0 - C09 |
3,207,694 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C09, |
| 39 |
GPL5240 |
AFFY Human Phase3 v1.0 - C07 |
3,203,753 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C07, |
| 40 |
GPL5316 |
AFFY Human Phase3 v1.0 - C83 |
3,191,550 |
Affymetrix, Inc. |
2007-05-23 |
Affymetrix |
Homo sapiens
 |
GeneChip |
in situ oligonucleotide, AFFY Human Phase3 v1.0 - C83, |
|